early stage
Showing 1 - 2 of 2
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)
Completed
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- +7 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Jun 6, 2022
Breast Cancer, Early Stage, Triple Negative Breast Cancer Trial in United States (Enzalutamide, assessment)
Active, not recruiting
- Breast Cancer
- +2 more
- Enzalutamide
- assessment
-
Hartford, Connecticut
- +11 more
Apr 26, 2022